<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Lumasiran_Initial_Initiation_Q20_R6</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>a.	Milliner DS, Harris PC, Sas DJ, et al. Primary Hyperoxaluria Type 1. 2002 Jun 19 [Updated 2022 Feb 10]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Table 1. [Normal Values for Urinary Oxalate,...]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1283/table/ph1.T.normal_values_for_urinary_oxalate/
b.	Groothoff, J.W., Metry, E., Deesker, L. et al. Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope. Nat Rev Nephrol 19, 194–211 (2023). https://doi.org/10.1038/s41581-022-00661-1</questionText>
        <status>Active</status>
        <versionNumber>1</versionNumber>
    </assessmentQuestionVersion>
    <dataType>TextBlock</dataType>
    <developerName>Lumasiran_Initial_Initiation_Q20_R6</developerName>
    <name>Lumasiran_Initial_Initiation_Q20_R6</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
